AGP Executive Report
Last update: 10 hours agoReciprocal healthcare access: Australia’s Medicare-style reciprocal agreements cover eligible visitors from 11 countries plus the UK, Ireland, Malta and others, allowing access to medically necessary public inpatient/outpatient hospital care and some subsidised medicines—while elective procedures remain excluded. Psychedelic treatment directory: PsyAccess has launched a free, registry-verified directory listing licensed ketamine and psychedelic-assisted therapy providers across 27 European countries, highlighting uneven access, including Malta with just one verified provider. ALS drug setback: A phase 2 trial of the RIPK1 inhibitor DNL788 (SAR443820) in adults with ALS found it did not slow functional decline and was linked to more adverse events and discontinuations. Storm recovery funding: The EU has proposed €489m from the Solidarity Fund for recovery from January–February 2026 storms and flooding, including support for Malta alongside Portugal, Spain and Italy. Online safety push: Australia’s approach to restricting children’s social media access is being used as a model for broader “digital duty of care” style reforms. Care workforce staffing gap: A care worker on a visa meant to fill shortages says her sponsor licence was revoked and she was left with no shifts. Mental health courts: A county in Virginia is seeking state funding to expand a court-supervised treatment docket for people with serious mental illness and substance-use disorders. Organic farming snapshot: Eurostat data show Serbia has very low organic farmland share (0.83%), with Malta among countries in the low group. Local health-related Malta link: Malta appears in multiple EU/Europe health policy and access stories this week, from reciprocal care to verified treatment listings.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.